Science Explorer Back to mapMap
Discussion
Researcher · Kyoto Pharmaceutical University · Japan

Tomonori Kunikata

Tomonori Kunikata publishes mostly in Pharmacology, Physiology and Surgery, on topics such as Inflammatory mediators and NSAID effects, Nitric Oxide and Endothelin Effects and Helicobacter pylori-related gastroenterology studies.

OpenAlex
World rank
#3,340,698
of 7,710,434 ranked researchers
Rank in Japan
#79,573
of 383,136
Works
29
Citations
1.1k
Citations per work
36.7
h-index
14
i10-index 16Top 39% in Pharmacology (Medicine)
Tomonori Kunikata

What does Tomonori Kunikata research?

Tomonori Kunikata's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (6%).

Health Sciences: 14 works · 49.4% of their workMedicine: 14 works · 49.4% of their workPharmacology: 6 works · 21.5% of their workPhysiology: 6 works · 19.0% of their workSurgery: 3 works · 8.9% of their workEverything else: 9 works · 31.6% of their workLife Sciences: 6 works · 19.0% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 8.9% of their workMolecular Biology: 3 works · 8.9% of their workImmunology and Microbiology: 2 works · 6.3% of their workImmunology: 2 works · 6.3% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 3.8% of their workPharmacology: 1 works · 3.8% of their workTHEIR WORKTomonori Kunikata29works
Life Sciences19%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1449.4%
  2. Everything else931.6%
    1. Biochemistry, Genetics and Molecular Biology38.9%
    2. Immunology and Microbiology26.3%
    3. Pharmacology, Toxicology and Pharmaceutics13.8%
  1. 1Pharmacology22% of their works
  2. 2Physiology19% of their works
  3. 3Surgery9% of their works
  4. 4Molecular Biology9% of their works
  5. 5Immunology6% of their works
  6. 6Pharmacology4% of their works

Research topics

Which keywords describe Tomonori Kunikata's research?

The keywords of their largest research topics: Inflammation, Cancer, Cyclooxygenase-2 Inhibitors, Prostaglandins, Endothelial Dysfunction, Nitric Oxide, Gastric Cancer and Helicobacter pylori.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Inflammation407 topics
  2. Cancer152 topics
  3. Cyclooxygenase-2 Inhibitors121 topic
  4. Prostaglandins121 topic
  5. Endothelial Dysfunction101 topic
  6. Nitric Oxide101 topic
  7. Gastric Cancer71 topic
  8. Helicobacter pylori71 topic
  9. Allergic Disease31 topic
  10. Allergic Diseases31 topic
  11. Antibiotic Pharmacokinetics31 topic
  12. Asthma31 topic
  13. Critically Ill Patients31 topic
  14. Glycyrrhizin31 topic
  15. Licorice31 topic
  16. Mast Cells31 topic
  17. Arachidonic Acid21 topic
  18. Epoxyeicosatrienoic Acids21 topic

Where does Tomonori Kunikata work?

Tomonori Kunikata's main affiliation in the publication record is Kyoto Pharmaceutical University, Japan.

How many publications and citations does Tomonori Kunikata have?

OpenAlex counts 29 works and 1,065 citations for Tomonori Kunikata, an h-index of 14, ranking #3,340,698 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tomonori Kunikata. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.